Jansson Britt, Karvanen Matti, Cars Otto, Plachouras Diamantis, Friberg Lena E
Division of Pharmacokinetics and Drug Therapy, Department of Biopharmaceutical Sciences, Biomedicum, Box 591, SE-75124 Uppsala, Sweden.
J Pharm Biomed Anal. 2009 Apr 5;49(3):760-7. doi: 10.1016/j.jpba.2008.12.016. Epub 2008 Dec 24.
An analytical method for quantitation of colistin A and colistin B in plasma and culture medium is described. After protein precipitation with acetonitrile (ACN) containing 0.1% trifluoroacetic acid (TFA), the supernatants were diluted with 0.03% TFA. The compounds were separated on an Ultrasphere C18 column, 4.6 mm x 250 mm, 5 microm particle size with a mobile phase consisting of 25% ACN in 0.03% TFA and detected with tandem mass spectrometry. The instrument was operating in ESI negative ion mode and the precursor-product ion pairs were m/z 1167.7-->1079.6 for colistin A and m/z 1153.7-->1065.6 for colistin B. The lower limit of quantification (LLOQ) for 100 microL plasma was 19.4 and 10.5 ng/mL for colistin A and B, respectively, with CV <6.2% and accuracy <+/-12.6%. For culture medium (50 microL+50 microL plasma), LLOQ was 24.2 and 13.2 ng/mL for colistin A and B, respectively, with CV <11.4% and accuracy <+/-8.1%. The quick sample work-up method allows for determination of colistin A and B in clinical samples without causing hydrolysis of the prodrug colistin methanesulfonate (CMS).
本文描述了一种定量测定血浆和培养基中多粘菌素A和多粘菌素B的分析方法。用含0.1%三氟乙酸(TFA)的乙腈(ACN)进行蛋白沉淀后,上清液用0.03% TFA稀释。化合物在4.6 mm×250 mm、5 µm粒径的Ultrasphere C18柱上分离,流动相为含25% ACN的0.03% TFA,并用串联质谱检测。仪器在电喷雾负离子模式下运行,多粘菌素A的前体-产物离子对为m/z 1167.7→1079.6,多粘菌素B的前体-产物离子对为m/z 1153.7→1065.6。100 µL血浆中多粘菌素A和B的定量下限(LLOQ)分别为19.4和10.5 ng/mL,变异系数(CV)<6.2%,准确度<±12.6%。对于培养基(50 µL + 50 µL血浆),多粘菌素A和B的LLOQ分别为24.2和13.2 ng/mL,CV <11.